R. MassI

Hematological Profile of Adult Haemoglobin SS and SC Sickle Cell Patients in Stationary Phase: Evidences from National Teaching Hospital of Cotonou in Benin

A. Zohoun, T. Baglo-Agbodande, B. Houssou, R. MassI, E. Kassehin, G. G. Orou Guiwa, J. Dèhoumon, J. Mehou, L. Anani, A. Vovor & D. Kinde-Gazard · International Blood Research & Reviews · 2023

Background and Objective: Sickle cell disease is a major public health problem. The aim of this study was to determine the hematological parameters in the inter-critical period of adult sickle cell patients at the National Teaching Hospital CNHU-HKM of Cotonou. Materials and Meth...

Open access Research Article 10.9734/ibrr/2023/v14i4319

The JAK2 V617F Mutation in Chronic Myeloid Leukaemia within a BCR-ABL Positive Cohort of Beninese Patients

S. Azonbakin, B. Houssou, I. Azannai, B. Awede, R. MassI, M. Adjagba, A. Agbalinsou, L. Anani, R. Darboux, F. Gangbo & A. Laleye · International Blood Research & Reviews · 2018

Chronic myelogenous leukaemia (CML) is an acquired myeloproliferative disorder (MPD) characterized by a chromosomal abnormality (the Philadelphia chromosome) that causes the chimeric BCR-ABL oncogene. An acquired genetic mutation in exon 12 of the JAK2 tyrosine kinase gene leadin...

Open access Research Article 10.9734/IBRR/2018/39436